We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS PR Newswire MINNEAPOLIS, April 10, 2024 MINNEAPOLIS, April 10, 2024 /PRNewswire/...
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY PR Newswire MINNEAPOLIS, April 8, 2024 Advanced Cell Diagnostics (ACD) achieves significant global customer...
BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE PR Newswire MINNEAPOLIS, April 3, 2024 MINNEAPOLIS, April 3, 2024 /PRNewswire/ -- Bio-Techne...
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS PR Newswire MINNEAPOLIS, April 1, 2024 MINNEAPOLIS, April 1, 2024 /PRNewswire/ -- Bio-Techne...
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES PR Newswire MINNEAPOLIS, March 28, 2024 MINNEAPOLIS, March 28, 2024 /PRNewswire/...
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA PR Newswire MINNEAPOLIS, March 22, 2024 The QuantideX® qPCR BCR-ABL IS Kit is now compliant...
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM PR Newswire MINNEAPOLIS, March 12, 2024 MINNEAPOLIS, March 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, March 6, 2024 MINNEAPOLIS, March 6, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5.97 | -8.76780731385 | 68.09 | 68.52 | 61.16 | 1026476 | 63.96185438 | CS |
4 | -10.2 | -14.1039823009 | 72.32 | 72.455 | 61.16 | 1008974 | 67.72192162 | CS |
12 | -10.48 | -14.435261708 | 72.6 | 78.745 | 61.16 | 1105181 | 70.34149718 | CS |
26 | -4.22 | -6.36116973169 | 66.34 | 78.745 | 51.79 | 1162102 | 67.69869124 | CS |
52 | -21.93 | -26.0916121356 | 84.05 | 89.91 | 51.79 | 1031849 | 72.55878528 | CS |
156 | -41.6925 | -40.1613485852 | 103.8125 | 135.9625 | 51.79 | 611129 | 80.75295673 | CS |
260 | 14.84 | 31.3874788494 | 47.28 | 135.9625 | 38.7925 | 438036 | 77.88185924 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions